These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 2513570)

  • 1. A humanized antibody that binds to the interleukin 2 receptor.
    Queen C; Schneider WP; Selick HE; Payne PW; Landolfi NF; Duncan JF; Avdalovic NM; Levitt M; Junghans RP; Waldmann TA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10029-33. PubMed ID: 2513570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.
    Mateo C; Moreno E; Amour K; Lombardero J; Harris W; Pérez R
    Immunotechnology; 1997 Mar; 3(1):71-81. PubMed ID: 9154469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.
    Kolbinger F; Saldanha J; Hardman N; Bendig MM
    Protein Eng; 1993 Nov; 6(8):971-80. PubMed ID: 8309946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanization of an anti-p185HER2 antibody for human cancer therapy.
    Carter P; Presta L; Gorman CM; Ridgway JB; Henner D; Wong WL; Rowland AM; Kotts C; Carver ME; Shepard HM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4285-9. PubMed ID: 1350088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
    Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
    Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
    Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
    J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric and humanized antibodies with specificity for the CD33 antigen.
    Co MS; Avdalovic NM; Caron PC; Avdalovic MV; Scheinberg DA; Queen C
    J Immunol; 1992 Feb; 148(4):1149-54. PubMed ID: 1737932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities.
    Rose B; Gillespie A; Wunderlich D; Barbosa JA; Cahill K; Dzuiba J; Shedd D; Zerler B
    Mol Immunol; 1992 Jan; 29(1):131-44. PubMed ID: 1731187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
    Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
    Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of murine monoclonal antibodies through variable domain resurfacing.
    Roguska MA; Pedersen JT; Keddy CA; Henry AH; Searle SJ; Lambert JM; Goldmacher VS; Blättler WA; Rees AR; Guild BC
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):969-73. PubMed ID: 8302875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response toward beta-adrenergic ligands and their receptors. VIII. Extensive diversity of VH and VL genes encoding anti-alprenolol antibodies.
    Nahmias C; Strosberg AD; Emorine LJ
    J Immunol; 1988 Feb; 140(4):1304-11. PubMed ID: 3125254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized antibodies for antiviral therapy.
    Co MS; Deschamps M; Whitley RJ; Queen C
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2869-73. PubMed ID: 1849279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.